Role of Biomarkers in the Development of PARP Inhibitors - Wikidata - wikimedia - TriplyDB

Role of Biomarkers in the Development of PARP Inhibitors

Role of Biomarkers in the Development of PARP Inhibitors

http://www.wikidata.org/entity/Q26753159

about

PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting.Exposure-Response of Veliparib to Inform Phase II Trial Design in Refractory or Relapsed Patients with Hematological Malignancies.PARP Inhibitors in Prostate Cancer.TGFbeta and miRNA regulation in familial and sporadic breast cancer.A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response Tissue-based biomarkers in prostate cancer.RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells.

P2860

Q37668511-A43E8494-6FE4-488B-B849-D5F8A293FC9B Q38656601-B5AE7FDC-C570-40DF-B332-3C7F7C13C6AB Q39328164-298CF88D-A9F2-4C07-B141-5FED20A5A774 Q41612388-D08196B5-9F6E-4354-8743-6C9072C3EA81 Q42725737-C26ABA04-B8AD-4D79-BEE2-D390195A059C Q47144748-8B18541B-7C3A-479B-B95C-8762FDD15B73 Q47156447-80D242F8-1D51-4DC3-84C1-0B766FB5C686

P2860

Role of Biomarkers in the Development of PARP Inhibitors

http://www.wikidata.org/entity/Q26753159

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Role of Biomarkers in the Development of PARP Inhibitors

@ast

Role of Biomarkers in the Development of PARP Inhibitors

@en

Role of Biomarkers in the Development of PARP Inhibitors

@nl

type

label

Role of Biomarkers in the Development of PARP Inhibitors

@ast

Role of Biomarkers in the Development of PARP Inhibitors

@en

Role of Biomarkers in the Development of PARP Inhibitors

@nl

prefLabel

Role of Biomarkers in the Development of PARP Inhibitors

@ast

Role of Biomarkers in the Development of PARP Inhibitors

@en

Role of Biomarkers in the Development of PARP Inhibitors

@nl

P1433

Q26753159-274A33F7-C567-4298-A737-AAB4D8BB9111

P1476

Q26753159-09726E89-1DED-4D7C-B599-485CF988D867

P2093

Q26753159-10A9F7EA-5C8C-411B-B493-EF35FDEC6398

Q26753159-D7C27740-23E4-467A-AF42-BB26C491A12F

Q26753159-F941E92F-7E56-486E-8B61-548F6E1BFADD

Q26753159-FE9B4D75-A3EC-475E-820B-CC2C99B886E8

P2860

Q26753159-00E200FB-D99C-45E4-B41B-9F4717707FC6

Q26753159-011897AB-4ED2-4BE3-989E-939343EB2200

Q26753159-01522001-A63B-4EDF-B1D3-F49BAFD2077C

Q26753159-0163800E-0D8B-4FA1-9A4E-DFDFA81E1F6B

Q26753159-0F759679-5BEC-4520-BB03-4312D0122B58

Q26753159-103B0A79-80D2-4B58-BE8D-666B383D9C38

Q26753159-1A9466A0-0484-4B12-88A9-DC6F7A9B284B

Q26753159-1AC4BEC8-F6DB-4DE6-8A1F-EC52A185076F

Q26753159-1E1B5C47-B38C-4A2F-8264-C3D8A46CE17E

Q26753159-1E278C2C-D7DE-4273-8AF9-B2F16A8988FC

P304

Q26753159-D48FE201-A91F-4F8F-823B-D700C3EE904B

P31

Q26753159-4AFDBC5A-E63C-4ED3-A92D-98AA53127315

P356

Q26753159-908EE138-A34C-4670-AA24-A878EAA86A7B

P407

Q26753159-E1191624-3D2A-47D8-96A0-CA894F07F410

P433

Q26753159-70365027-0C3D-4D0D-B918-66F22C1F5B36

P478

Q26753159-C76D231F-3C08-4820-8593-9EF8F520876B

P50

Q26753159-3E24B2BB-058C-4575-9775-DB97D36B168C

P577

Q26753159-2D8AD931-3608-4BDF-97F8-C969DC46D93D

P5875

Q26753159-4C1A44F3-5A82-4A83-94B0-3D3E88AC0779

P698

Q26753159-FE49C507-B392-4683-8771-DF908C48AC27

P921

Q26753159-7B1B72DA-156C-42DB-A819-69F79BFB2DB1

P932

Q26753159-A827C043-EA39-434D-813F-3A6315331972

P356

P1433

Biomarkers in cancer

P1476

Role of Biomarkers in the Development of PARP Inhibitors

@en

P2093

Bratati Ganguly

http://www.w3.org/2001/XMLSchema#string

Kim M Hirshfield

http://www.w3.org/2001/XMLSchema#string

Shridar Ganesan

http://www.w3.org/2001/XMLSchema#string

Sonia C Dolfi

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies

The role of poly(ADP-ribose) in the DNA damage signaling network

Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins

Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1

XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage

6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

Profile of veliparib and its potential in the treatment of solid tumors

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

P304

15-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/BIC.S36679

http://www.w3.org/2001/XMLSchema#string

P407

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Lorna Rodriguez-Rodriguez

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297721981

http://www.w3.org/2001/XMLSchema#string

P698

26997874

http://www.w3.org/2001/XMLSchema#string

P921

P932

4786099

http://www.w3.org/2001/XMLSchema#string